Biatain. Det sikre valg til væskende sår. Så enkelt er det

Oversigt over vigtige Biatain referencer:

Reference 1: Cherry et al. The burden of venous leg ulcers in Europe: A review of the literature. Poster presented at ETRS, 2001.

Reference 2: Jørgensen et al. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: A randomised, controlled trial. International Wound Journal. 2005;2(1):64-73.

Reference 3: Flanagan. Barriers to the implementation of best practice in wound care. Wounds UK. 2005;1(3):74-82.

Reference 4: Kerstein et al. Cost and cost effectiveness of venous and pressure ulcer protocols of care. Disease Management & Health Outcomes. 2001;9(11):651-663.

Reference 5: Jørgensen et al. A randomised, controlled trial on safety and performance of a new foam dressing on venous leg ulcers. Submitted to EWMA 2008 and WUWHS 2008

Reference 6: Karlsmark et al. Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers. Journal of Wound Care. 2003;12(9):351-354.

Reference 7: Münter et al. Effect of a sustained silverreleasing dressing on ulcers with delayed healing: the CONTOP study. Journal of Wound Care. 2006;15(5):199-206.

Reference 8: Rayman et al. Sustained silver-releasing dressing in the treatment of diabetic foot ulcers. British Journal of Nursing.2005;14(2):109-114.

Reference 9: Durante et al. Improved health related activities of daily living for patients with wound pain treated with an ibuprofen foam dressing. Poster presented at EWMA, 2007.

Reference 10: Gottrup et al. Less pain with Biatain - Ibu: Initial findings from a randomized, controlled, double-blind clinical investigation on painful venous leg ulcers. International Wound Journal. 2007;4[suppl.1]:24-34.

Reference 11: Jørgensen et al. Pain and quality of life for patients with venous leg ulcers: Proof of concept of the efficacy of Biatain Ibu, a new pain reducing wound dressing. Wound Repair and Regeneration. 2006;14(3):233-239.

Reference 12: Sibbald et al. A pilot (real-life) randomised clinical evaluation of a pain-relieving foam dressing: (Ibuprofen foam versus local best practice). International Wound Journal. 2007;4[suppl.1]:16-23.

Reference 13: Andersen et al. A randomized, controlled study to compare the effectiveness of two foam dressings in the management of lower leg ulcer. Ostomy/Wound Management. 2002;48(8): 34-41.

Reference 14: Lohmann et al. Safety and performance of a new non-adhesive foam dressing for the treatment of diabetic foot ulcers. Journal of Wound Care. 2004;13(3):118-120.

Reference 15: López-Jiménez et al. Performance of a new adhesive foam dressing for heel ulcers. Poster presented at EPUAP, 2002.

Reference 16: Caring for patients with difficult to heal ulcers. In preparation.

Reference 17: Bale et al. Time to healing and HRQoL in the treatment of pressure ulcers with foam dressings. Poster presented at EWMA, 2002.

Reference 18: Larsen et al. Evaluation of a foam dressing with a new soft adherent layer. Poster presented at joint scientific meeting of ETRS, EWMA, and DGfW, 2005.

Reference 19: Thomas et al. An in-vitro comparison of the physical characteristics of hydrocolloids, hydrogels, foams and alginate/CMC fibrous dressings. www.dressings.org, 2005.

Reference 20: Severin & Kristensen. New test method for measuring absorption in foams. Poster presented at joint Scientific meeting of ETRS, EWMA and DGfW, 2005.

Reference 21: Collier. The challenge of wound exudate. Nursing Times. 2003;99(5):47-8.

Reference 22: Moffat. Pain as a Predictor of Leg Ulcer Healing. in How to Decrease Trauma and Pain at Dressing changes. Symposium abstract presented at SAWC, 2007.

Reference 23: Niv D et al. EFIC’s Declaration on chronic pain as a major healthcare problem, a disease in its own right. www.painreliefhumanright.com, 2001.

Reference 24: Price et al. Managing painful chronic wounds: the Wound Pain Management Model. International Wound Journal. 2007;4[suppl.1]:4-15.

Reference 25: McCaffery. Nursing practice theories related to cognition, bodily pain, and man-environment interactions. 1968. Los Angeles: UCLA Students’ Store.

Reference 26: Steffansen & Herping. Novel wound models for characterizing the effects of exudate levels on the controlled release of ibuprofen from foam dressings. Poster presented at EWMA, 2006.

Reference 27: Flanagan et al. Case series investigating the experience of pain in patients with chronic venous leg ulcers treated with a foam dressing releasing ibuprofen. www.worldwidewounds.com, 2006.

Reference 28: Maggio et al. Reducing wound pain with an ibuprofen foam dressing in real life settings. Poster presented at EWMA, 2007.

Reference 29: Ip et al. Antimicrobial activities of silver dressings: an in vitro comparison. Journal of Medical Microbiology 2006;(55):59-63.

Reference 30: Sibbald et al. Preparing the wound bed – debridement, bacterial balance and moisture balance. Ostomy/Wound Management. 2000;46(11):14-35.

Reference 31: Dolmer et al. In vitro silver release profiles for various antimicrobial dressings. Poster presented at WUWHS, 2004.

Reference 32: Lansdown et al. Contreet Foam and Contreet Hydrocolloid: an insight into two new silver-containing dressings. Journal of Wound Care. 2003;12(6):205-210.

Reference 33: Scanlon et al. Cost-effective faster wound healing with a sustained silverreleasing foam dressing in delayed healing leg ulcers, a health economic analysis. International Wound Journal. 2005;2(2):150-160.

Reference 34: White. An historical overview of the use of silver in wound management. British Journal of Nursing. 2001;10(15)[Suppl.]:3-8.